MR lymphangiography

PROCEDURE2 trials

Sponsors

Cancer Institute Ariake Hospital, M.D. Anderson Cancer Center

Conditions

Bladder CancerGenitourinary CancerProstate Cancerlymphedema

Unknown Phase

A Validation Study of MR Lymphangiography Using SPIO, a New Lymphotropic Superparamagnetic Nanoparticle Contrast

TerminatedNCT00147238

M.D. Anderson Cancer CenterBladder Cancer, Genitourinary Cancer, Prostate Cancer

Start: 2005-07-31End: 2007-01-31Updated: 2012-08-07

MR lymphangiography for preoperative assesment of secondary lymhedema

RecruitingJPRN-UMIN000003119

Cancer Institute Ariake Hospitallymphedema

Start: 2010-02-01Target: 30Updated: 2026-06-29